PTPI OTC
Petros Pharmaceuticals, Inc.
1W: -6.2%
1M: -20.2%
3M: -23.5%
YTD: -53.1%
1Y: -85.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+13.64%)
Weekly Expected Move ±50.8%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-01-21
Earliest Filing
2022-01-24
Latest Filing
partner: 5
Counterparties (Filed by PTPI)
5 relationshipsCompanies named in PTPI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Metuchen Pharmaceuticals LLC | — | partner | Wholly owned subsidiary of Petros Pharmaceuticals Inc. entering technology transfer agreement | 2022-01-24 | View |
| Patheon Pharmaceuticals Inc. | — | partner | Contract manufacturer providing technology transfer services for Stendra tablets | 2022-01-24 | View |
| Thermo Fisher Scientific | TMO | partner | Parent company of Patheon Pharmaceuticals Inc. | 2022-01-24 | View |
| Metuchen Pharmaceuticals LLC | — | partner | Wholly owned subsidiary of Petros Pharmaceuticals Inc. that entered into a settlement agreement with VIVUS LLC regarding | 2022-01-21 | View |
| VIVUS LLC | — | partner | Delaware limited liability company that entered into a settlement agreement with Metuchen Pharmaceuticals LLC involving | 2022-01-21 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-30 | Officer/Director Change | View | |
| 2026-06-18 | Officer/Director Change; Exhibits | View | |
| 2026-06-05 | Officer/Director Change | View | |
| 2026-01-02 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-07 | Notice of Delisting or Transfer | View | |
| 2025-09-05 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-06-20 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-05-21 | Notice of Delisting or Transfer | View | |
| 2025-05-02 | Notice of Delisting or Transfer; Material Modification to Rights of Security Holders; Amendments to | View | |
| 2025-04-11 | Notice of Delisting or Transfer; Material Modification to Rights of Security Holders; Departure/Elec | View | |
| 2025-04-09 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-02-21 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-01-24 | Entry into Material Definitive Agreement; Material Modification to Rights of Security Holders; Amend | Agreement | View |
| 2024-12-16 | Triggering Events That Accelerate Obligation; Financial Statements and Exhibits | View | |
| 2024-11-21 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-10-18 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-10-17 | Entry into Material Definitive Agreement; Material Modification to Rights of Security Holders; Amend | Agreement | View |
| 2024-10-04 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-09-19 | Shareholder Nominations | View | |
| 2024-01-12 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR